Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 23, 2013Achieves All Year-End Clinical Milestones
Aratana Therapeutics, Inc., (Nasdaq: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today provided a year-end...
-
Dec 11, 2013
Aratana Therapeutics (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it will...
-
Nov 20, 2013
Aratana Therapeutics, Inc. (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced positive...
-
Nov 19, 2013
Aratana Therapeutics, Inc. (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it will...
-
Nov 13, 2013Conference Call tomorrow Thursday, November 14, 2013, at 8 a.m. Eastern Time
Aratana Therapeutics, Inc. (NASDAQ: PETX) today announced its third quarter 2013 financial results and recapped its development activities.